Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
05/2014
05/08/2014US20140127184 Compounds for the treatment of neuropsychiatric disorders
05/08/2014US20140127171 Treatment of chronic post-traumatic encephalopathy
05/08/2014US20140127163 Use of slurp1 as an imunomodulatory molecule in the ocular surface
05/08/2014US20140127160 Treatment of hepatitis c virus with telaprevir (vx-950) in patients non-responsive to treatment with pegylated interferon-alpha 2a/2b and ribavirin
05/08/2014US20140127156 Hepatitis C Virus Inhibitors
05/08/2014US20140127155 Smac mimetic dimers and trimers useful as anti-cancer agents
05/08/2014US20140127154 Pregnancy hormone combination for treatment of autoimmune diseases
05/08/2014US20140127134 Treatment and prevention of cancer with hmgb1 antagonists
05/08/2014DE102005030614B4 Zellfreies Transplantat, dessen Verwendung, Verfahren zu dessen Herstellung, dabei hergestellte Matrix mit Gel und Verfahren zur Herstellung dieser Matrix mit Gel A cell-free graft, the use thereof, processes for its production, with gel matrix produced thereby and processes for preparing this matrix with gel
05/07/2014EP2727604A1 Antipruritic agent
05/07/2014EP2727590A1 Compositions for treating centrally mediated nausea and vomiting
05/07/2014EP2727588A1 Baclofen and acamprosate based therapy of neurological disorders
05/07/2014EP2727583A2 Drug carrier and drug carrier kit for inhibiting fibrosis
05/07/2014EP2727581A1 Injectable composition combining a filling agent and a fibroblast growth medium
05/07/2014CN103781496A 用于治疗hcv的方法 The method for treating hcv
05/07/2014CN103768604A 治疗性肿瘤疫苗 Therapeutic cancer vaccine
05/07/2014CN103768603A 一种产畜助产子宫灌注液 One kind of livestock production midwifery uterine perfusion fluid
05/07/2014CN103768602A 一种靶向炎症的复合物、其制备方法及应用 One kind of targeting inflammatory compound, its preparation method and application
05/07/2014CN103768601A 抑制micro-RNA155用于预防和治疗动脉粥样硬化的方法 Method of inhibiting micro-RNA155 for the prevention and treatment of atherosclerosis
05/07/2014CN103768600A 一种磁性热敏脂质体纳米金复合物、制备方法及应用 A magnetic thermosensitive liposomes nano-gold complexes, preparation method and application
05/07/2014CN103768597A 一种负载5-氨基乙酰丙酸的富勒烯水溶性衍生物的合成方法与应用 A synthetic method of 5-aminolevulinic acid load of water-soluble fullerene derivative and Applications
05/07/2014CN103768008A 基于改良凝胶基质的儿童型口服核苷类抗病毒药用凝胶单元及其制备方法 Based on the children's modified gel matrix type oral nucleoside antiviral gel unit and its preparation method
05/07/2014CN103041406B 模板法制备诊疗协同纳米颗粒释放体系的方法 Template Preparation synergistic treatment methods of nanoparticle delivery system
05/07/2014CN103006782B 大果榕提取物及其在制备治疗骨质疏松药物中的应用 Ficus auriculata extract and its application in the manufacture of a medicament for the treatment of osteoporosis
05/07/2014CN102733088B 一种温敏性聚n-异丙基丙烯酰胺/聚氨酯载药电纺纤维膜及其制备方法 Temperature and sensitive poly n- isopropylacrylamide / polyurethane drug electrospun fiber membrane and its preparation method
05/07/2014CN102552908B 含青蒿素及青蒿素类衍生物和Bcl-2抑制剂的药物组合物及其应用 Containing artemisinin and artemisinin derivatives and Bcl-2 inhibitor pharmaceutical compositions and applications
05/07/2014CN102441168B 含芹菜素及芹菜素类衍生物和Bcl-2抑制剂的药物组合物及其在制备治疗癌症的药物中的应用 Containing apigenin and apigenin derivatives and Bcl-2 inhibitors and pharmaceutical compositions for the preparation of drugs for treating cancer
05/07/2014CN102441167B 含有芹菜素及芹菜素类衍生物和组蛋白去乙酰化酶抑制剂的药物组合物及其应用 Containing apigenin and apigenin derivatives and histone deacetylase inhibitor pharmaceutical composition and its application
05/07/2014CN102416179B 用于哮喘的吸入性复方组合物 For asthma inhaled compound composition
05/07/2014CN101686959B 作为血小板adp受体抑制剂的化合物的组合疗法 Combination therapy as inhibitors of platelet adp receptor compound
05/07/2014CN101528731B 具有AuroraA选择性抑制作用的氨基吡啶衍生物 Selective inhibition has AuroraA aminopyridine derivative
05/06/2014US8716455 Genetic products differentially expressed in tumors and use thereof
05/06/2014US8716445 Compositions comprising signal peptide-containing proteins
05/06/2014US8716348 Formoterol/steroid bronchodilating compositions and methods of use thereof
05/06/2014US8716347 Tramadol for the treatment of functional gastrointestinal disorders
05/06/2014US8716346 Alkylating agent combinations in the treatment of cancer
05/06/2014US8716344 Class- and isoform-specific HDAC inhibitors and uses thereof
05/06/2014US8716323 Cyclic protein tyrosine kinase inhibitors
05/06/2014US8716306 Carboxamide bioisosteres of opiates
05/06/2014US8716301 Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation
05/06/2014US8716295 Fluoroquinolone derivatives or sulfonamide moiety-containing compounds as inhibitors of tyrosyl-dnaphosphodiesterase (TDP1)
05/06/2014US8716264 Compositions and methods for combination antiviral therapy
05/06/2014US8716253 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes
05/06/2014US8715968 Methods and reagents for modulating cholesterol levels
05/06/2014US8715697 Genes associated with Leishmania parasite virulence
05/06/2014US8715668 Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor DR5 and uses thereof
05/06/2014US8715649 Compositions and methods of use for alpha-1 antitrypsin having no significant serine protease inhibitor activity
05/06/2014CA2743731C Method of modulating the proliferation of medullary thyroid carcinoma cells
05/06/2014CA2655355C Use of rpn2 gene expression inhibitor
05/06/2014CA2628305C Jelly composition
05/06/2014CA2585638C Aminopyridine derivatives having aurora a selective inhibitory action
05/06/2014CA2526150C Treatment of humans with colloidal silver composition
05/06/2014CA2511838C Uses of mammalian cytokine; related reagents
05/06/2014CA2475446C Viral variants with altered susceptibility to nucleoside analogs and uses thereof
05/01/2014WO2014065769A1 Formulations for oral suspensions comprising antibiotics
05/01/2014WO2014065374A1 Therapeutic or prophylactic agent for retinopathy of prematurity, method of testing for retinopathy of prematurity, and screening method for therapeutic or prophylactic substance for retinopathy of prematurity
05/01/2014WO2014065341A1 Therapeutic agent for amyotrophic lateral sclerosis
05/01/2014WO2014064811A1 Pulmonary hypertension therapeutic agent
05/01/2014WO2014063923A1 Quinone based nitric oxide donating compounds for ophthalmic use
05/01/2014WO2014063868A1 Galactagogue compositions based on phosphatidylserine
05/01/2014WO2014063427A1 Method for screening drugs and used for drug for promoting the crosslinking of extracellular matrix and use thereof
05/01/2014WO2014028560A3 T-cell redirecting bispecific antibodies for treatment of disease
05/01/2014WO2013185764A3 Pharmaceutical compositions for combination therapy
05/01/2014US20140121264 MICRORNA (miRNA) AND DOWNSTREAM TARGETS FOR DIAGNOSTIC AND THERAPEUTIC PURPOSES
05/01/2014US20140121254 Pharmaceutical compositions for the treatment of movement disorders
05/01/2014US20140121248 Metalloenzyme inhibitor compounds
05/01/2014US20140121237 Methods for Inhibiting Virus Replication
05/01/2014US20140121229 Combination comprising s-[2-([[1-(2-ethylbutyl)cyclohexyl] carbonyl]amino)phenyl] 2-methylpropanethioate and an hmg coa reductase inhibitor
05/01/2014US20140121225 Polymorph of linagliptin benzoate
05/01/2014US20140121215 Process for the preparation of amorphous imatinib mesylate
05/01/2014US20140121211 Thiol mediated/activated prodrugs of sulfur dioxide (so2) having anti-bacterial activity
05/01/2014US20140121204 Novel dihydropyrimidinoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders.
05/01/2014US20140121202 S-t-BUTYL PROTECTED CYSTEINE DI-PEPTIDE ANALOGS AND RELATED COMPOUNDS
05/01/2014US20140121199 (THIENO[2,3-b][1,5]BENZOXAZEPIN-4-YL)PIPERAZIN-1-YL COMPOUNDS AS DUAL ACTIVITY H1 INVERSE AGONISTS/5-HT2A ANTAGONISTS
05/01/2014US20140121193 Methods for treating fibromyalgia
05/01/2014US20140121191 Oral Energy Supplement and Related Methods
05/01/2014US20140121185 Compounds and compositions for use in the treatment and prevention of cancer and precancerous conditions, inflammation-related disorders, pain and fever
05/01/2014US20140121178 Method and improved pharmaceutical composition for improving the absorption of an ester prodrug
05/01/2014US20140121175 Antitumor agent
05/01/2014US20140121169 Guanylate Cyclase Receptor Agonists For The Treatment Of Tissue Inflammation And Carcinogenesis
05/01/2014US20140121166 Compositions and methods for the treatment of juvenile neuronal ceroid lipofuscinosis and related disorders
05/01/2014US20140121161 Repairing bruch's membrane with hydrogels
05/01/2014US20140121155 Crystal Forms of Saxagliptin and Processes for Preparing Same
05/01/2014US20140121152 Active Agent Prodrugs with Heterocyclic Linkers
05/01/2014US20140120185 Combinations comprising brexpiprazole or a salt thereof and a second drug for use in the treatment of a cns disorder
05/01/2014US20140120180 Metal compounds mixed or sulphated, as phosphate binders
05/01/2014US20140120175 Visual Performance and/or Macular Pigmentation
05/01/2014US20140120157 Targeted liposomes
05/01/2014US20140120156 Compositions and methods for exosome targeted expression
05/01/2014US20140120141 Peptides useful in the treatment and care of the skin and mucous membranes and their use in cosmetic or pharmaceutical compositions
05/01/2014US20140120121 Medicinal treatment of atopic inflammatory diseases
05/01/2014US20140120117 Treatment of tumors using specific anti-l1 antibody
05/01/2014US20140120104 Cadherin-11 ec1 domain antagonists for treating inflammatory joint disorders
05/01/2014US20140120089 Antibodies to insulin-like growth factor i receptor
05/01/2014US20140120087 Triazolopyridines
05/01/2014US20140120083 Treatment of cancers using pi3 kinase isoform modulators
05/01/2014US20140120081 Use of carbon nanomaterials with antioxidant properties to treat oxidative stress
05/01/2014US20140120074 Antimicrobial agents
05/01/2014US20140120063 Nutritional and metabolic approaches to prevent emergence of enteric pathogens
05/01/2014US20140120060 Treatment of rheumatoid arthritis and asthma using pi3 kinase inhibitors
1 ... 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 ... 1151